Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adaptica is an Italian ophthalmic medical device company focused on portable, AI-enabled tools for vision screening, refraction, and eye-care workflow. Founded in 2009 as a spin-off of the University of Padova, the company develops and manufactures products such as the 2WIN binocular vision screener, 2WIN-S/2WIN-S Plus screening systems, VisionFit SC wearable adaptive refractor, and the EyeROBO cloud/AI platform. Its products are designed to help eye-care specialists detect refractive errors, visual defects, and selected eye anomalies in clinics, screening programs, and remote-care settings. Adaptica is part of the He Vision Group and appears to remain an operating brand/company following its acquisition in 2018. The company has commercial distribution in more than 40 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adaptica.